<DOC>
	<DOCNO>NCT01476683</DOCNO>
	<brief_summary>This study design compare pharmacokinetics four product use treatment acute diarrhea .</brief_summary>
	<brief_title>Study Compare Pharmacokinetics Profiles Four Racecadotril Products</brief_title>
	<detailed_description>The study single dose , randomize , four -way , four-sequence crossover study 24 healthy subject , equal number male female ( minimum 10 either gender ) . Subjects drop replace . The four dos medication give study ( single dose four study period ) separate washout period least 7 calendar day . In study period , 17 blood sample pharmacokinetic analysis take 12 hour . Blood sample centrifuge concentration thiorphan ( active metabolite ) plasma measure use validated chromatographic assay . Pharmacokinetic parameter calculate plasma concentration data .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Racecadotril</mesh_term>
	<mesh_term>Thiorphan</mesh_term>
	<criteria>Male female subject ( equal number male female ) Volunteers age least 18 year old 55 year Subjects Body Mass Index ( BMI ) within protocolspecified parameter . Non exsmokers ; exsmoker define someone completely stop smoke least 12 month day 1 study . Clinical laboratory value within laboratory 's state normal range ; within range , must without clinical significance Have clinically significant disease capture medical history evidence clinically significant finding physical examination and/or clinical laboratory evaluation Has sign date informed consent document , indicate subject inform pertinent aspect study Willingness ability comply schedule visit , treatment plan , laboratory test , study procedure Seated pulse rate blood pressure within protocolspecified parameter . Relationship person involve directly conduct study ( i.e. , principal investigator ; subinvestigators ; study coordinator ; study personnel ; employee contractor sponsor Johnson &amp; Johnson subsidiary ; family ) Females pregnant lactating Females childbearing potential male female partner childbearing potential refuse use acceptable contraceptive regimen throughout entire duration study History significant hypersensitivity racecadotril relate product ( include excipients formulation ) well severe hypersensitivity reaction ( like angioedema ) drug Use certain drugs/medications within protocolspecified timeframes Medical history condition may , per protocol opinion investigator , adversely affect safety study subject compromise study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Antidiarrheals</keyword>
</DOC>